The incidence and predictors of HCC in REVEAL chronic hepatitis B patients with incident spontaneous HBsAg loss

被引：0
|
作者：
Jeng, Rachel Wen-Juei [1 ,2 ]
Pan, Mei-Hung [3 ]
Liu, Jessica [3 ]
Lee, Mei-Hsuan [4 ]
Batrla-Utermann, Richard [5 ]
Lu, Sheng-Nan [6 ]
Wang, Li-Yu [7 ]
Chen, Chien-Jen [3 ]
Yang, Hwai-I [3 ]
机构：
[1] Linkou Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Taoyuan, Taiwan
[2] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[3] Acad Sinica, Genom Res Ctr, Taipei, Taiwan
[4] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan
[5] Roche Diagnost, Basel, Switzerland
[6] Kaohsiung Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Kaohsiung, Taiwan
[7] Mackay Med Coll, New Taipei, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-1788
引用
收藏
页码：S725 / S725
页数：1
相关论文
共 50 条
  • [21] The incidence and predictors of hepatitis B surface antigen loss and hepatocellular carcinoma development after the cessation of lamivudine and entecavir treatment in chronic hepatitis B patients
    Chen, Chien-Hung
    Lee, Chuan-Mo
    Hung, Chao-Hung
    Wang, Jing-Houng
    Lu, Sheng-Nan
    Hu, Tsung-Hui
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 379 - 379
  • [22] Long-term incidence and predictors of hepatitis B surface antigen loss after discontinuing nucleoside analogues in noncirrhotic chronic hepatitis B patients
    Chen, C. -H.
    Hung, C. -H.
    Wang, J. -H.
    Lu, S. -N.
    Hu, T. -H.
    Lee, C. -M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (09) : 997 - 1003
  • [23] Models to predict hepatocellular carcinoma (HCC) in patients with chronic hepatitis B infection: The REVEAL - HBV study
    Chen, CJ
    Yang, HI
    Iloeje, UH
    Su, J
    Jen, CL
    You, SL
    Liaw, YF
    HEPATOLOGY, 2005, 42 (04) : 714A - 715A
  • [24] A risk function nomogram for predicting hcc in patients with chronic hepatitis B: The reveal.-HBV study
    Chen, C. J.
    Yang, H. I.
    Iloeje, U. H.
    Su, J.
    Jen, C. L.
    You, S. L.
    Sherman, M.
    Laiw, Y. F.
    Chen, P. J.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S180 - S180
  • [25] Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: A need for surveillance
    Kim, Gi-Ae
    Lee, Han Chu
    Kim, Min-Ju
    Ha, Yeonjung
    Park, Eui Ju
    An, Jihyun
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    JOURNAL OF HEPATOLOGY, 2015, 62 (05) : 1092 - 1099
  • [26] Incidence of Hepatocellular Carcinoma after HBsAg seroclearance in Chronic Hepatitis B patients: a need for Surveillance
    Kim, Gi-Ae
    Lee, Han Chu
    Ha, Yeonjung
    Park, Eui Ju
    An, Jihyun
    HEPATOLOGY, 2014, 60 : 972A - 972A
  • [27] Cumulative incidence and predictive factors of HBsAg Loss in Chronic Hepatitis Treated with Lamivudine
    Tsai, M-C
    Lee, C-M
    Chen, C-H
    Hu, T-H
    Hung, C-H
    Wang, J-H
    Lu, S-N
    Yen, Y-H
    Changchien, C-S
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A197 - A197
  • [28] IL-28B Genotypes in Spontaneous and Treatment Induced HBsAg Clearance of Chronic Hepatitis B Patients
    Hadziyannis, Emilia
    Laras, Andreas
    Panopoulou, Elieni
    Anagnostopoulou, Sofia
    Hadziyannis, Stephanos J.
    HEPATOLOGY, 2013, 58 : 633A - 634A
  • [29] Hepatitis B surface antigen (HBsAg) glycan isomer is predictive of HBsAg seroclearance in patients with chronic hepatitis B
    Ikeda, Yuji
    Murata, Ayato
    Nago, Hiroki
    Yamaguchi, Masahiro
    Om, Rihwa
    Terai, Yuichro
    Kita, Yuji
    Sato, Sho
    Sato, Shunsuke
    Shimada, Yuji
    Genda, Takuya
    HEPATOLOGY RESEARCH, 2024, 54 (10) : 888 - 898
  • [30] HBsAg loss in chronic hepatitis B: pointers to the benefits of curative therapy
    Dusheiko, Geoffrey
    Wang, Bo
    Carey, Ivana
    HEPATOLOGY INTERNATIONAL, 2016, 10 (05) : 727 - 729
12345